αCD22-TCRz-41BB CAR-T Cells
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for αCD22-TCRz-41BB CAR-T Cells, covering 2016-10-12 to 2016-10-12. Get the full timeline:
Most recent: Clinical Trial Update: Combination Transfer of αCD19-TCRz-41BB and αCD22-TCRz-41BB CAR-T Cells for B-cell Hematologic Malignancy [Phase 1, Phase 2]